|
Volumn 90, Issue 28, 2010, Pages 1986-1988
|
A 24-hour continuous infusion of paclitaxel in the treatment of advanced esophageal cancer
|
Author keywords
Continuous infusion; Esophageal neoplasms; Oxaliplatin; Paclitaxel
|
Indexed keywords
OXALIPLATIN;
PACLITAXEL;
ANTINEOPLASTIC AGENT;
PLATINUM COMPLEX;
ADULT;
ADVANCED CANCER;
ALOPECIA;
ARTICLE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CONTROL;
CANCER GROWTH;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL ARTICLE;
CONTINUOUS INFUSION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ESOPHAGEAL ADENOCARCINOMA;
ESOPHAGEAL SQUAMOUS CELL CARCINOMA;
HUMAN;
MYALGIA;
NEUROPATHY;
NEUTROPENIA;
TREATMENT RESPONSE;
VOMITING;
ADENOCARCINOMA;
AGED;
CANCER STAGING;
CLINICAL TRIAL;
ESOPHAGUS TUMOR;
INFUSION PUMP;
MIDDLE AGED;
PATHOLOGY;
SQUAMOUS CELL CARCINOMA;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARCINOMA, SQUAMOUS CELL;
ESOPHAGEAL NEOPLASMS;
HUMANS;
INFUSION PUMPS;
MIDDLE AGED;
NEOPLASM STAGING;
ORGANOPLATINUM COMPOUNDS;
PACLITAXEL;
|
EID: 84871454927
PISSN: 03762491
EISSN: None
Source Type: Journal
DOI: 10.3760/cma.j.issn.0376-2491.2010.28.012 Document Type: Article |
Times cited : (3)
|
References (14)
|